The NanoTest Vantage: next generation nanomechanical testing and materials development for the Pharmaceutical sector.
With its advanced scheduling capability enabling fully-automatic testing over an extended period, the NanoTest is ideally suited to research and quality assurance in a highly competitive industry where both high data throughput and reliability of results are essential.
Researchers from Pfizer have used their NanoTest to show that a brittleness index (H/Kc) determined from measurements on single crystals can be used in the effective prediction of the milling of pharmaceutical materials. The first step was to determine the fracture toughness. The wide load range possible in the NanoTest allows production of fully developed radial/median crack systems with a wide range of indenter geometries (e.g. cube corner, Berkovich, Vickers). The fracture toughness, together with the hardness derived from the nanoindentation, is used to determine the brittleness index.
Excellent correlation between the NanoTest nanoindentation data on single crystals and large pilot scale results have now been obtained for a wide range of materials providing significant cost savings for Pfizer.
Meet the Nanotest
Our support literature for the Pharmaceuticals sector will provide a great introduction to the NanoTest Vantage, learn how you could be taking advantage.
Download now
Subscribe to our Latest News